Standard BioTools Inc (NASDAQ: LAB) kicked off on Monday, up 4.76% from the previous trading day, before settling in for the closing price of $1.05. Over the past 52 weeks, LAB has traded in a range of $0.92-$2.41.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 8.27% over the last five years. While this was happening, its average annual earnings per share was recorded 55.77%. With a float of $365.93 million, this company’s outstanding shares have now reached $379.09 million.
The firm has a total of 818 workers. Let’s measure their productivity. In terms of profitability, gross margin is 47.04%, operating margin of -82.21%, and the pretax margin is -78.07%.
Standard BioTools Inc (LAB) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Standard BioTools Inc is 3.66%, while institutional ownership is 72.28%. The most recent insider transaction that took place on May 23 ’25, was worth 1,344. In this transaction Chief Financial Officer of this company sold 1,428 shares at a rate of $0.94, taking the stock ownership to the 930,286 shares. Before that another transaction happened on May 23 ’25, when Company’s SVP & Chief Business Officer sold 13,217 for $0.94, making the entire transaction worth $12,437. This insider now owns 843,076 shares in total.
Standard BioTools Inc (LAB) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 55.77% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 66.44% during the next five years compared to 11.61% growth over the previous five years of trading.
Standard BioTools Inc (NASDAQ: LAB) Trading Performance Indicators
Take a look at Standard BioTools Inc’s (LAB) current performance indicators. Last quarter, stock had a quick ratio of 5.37. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.36, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.15 in one year’s time.
Technical Analysis of Standard BioTools Inc (LAB)
Analysing the last 5-days average volume posted by the [Standard BioTools Inc, LAB], we can find that recorded value of 0.74 million was lower than the volume posted last year of 1.63 million. As of the previous 9 days, the stock’s Stochastic %D was 56.50%. Additionally, its Average True Range was 0.08.
During the past 100 days, Standard BioTools Inc’s (LAB) raw stochastic average was set at 20.22%, which indicates a significant decrease from 79.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.31% in the past 14 days, which was lower than the 77.59% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0973, while its 200-day Moving Average is $1.5372. Now, the first resistance to watch is $1.1200. This is followed by the second major resistance level at $1.1400. The third major resistance level sits at $1.1800. If the price goes on to break the first support level at $1.0600, it is likely to go to the next support level at $1.0200. Now, if the price goes above the second support level, the third support stands at $1.0000.
Standard BioTools Inc (NASDAQ: LAB) Key Stats
The company with the Market Capitalisation of 417.80 million has total of 379,822K Shares Outstanding. Its annual sales at the moment are 174,430 K in contrast with the sum of -138,890 K annual income. Company’s last quarter sales were recorded 40,800 K and last quarter income was -26,030 K.
